Skip to content
★ Sign in to follow
MJ

Michael John Dawson

Directeur Médical
Palisade Bio, Inc.
Total declarations
1
Company
1
▲ Purchases (1 ops.)
€15k
▼ Sales (0 ops.)
—

Latest filing published 31 Mar 2022 for Palisade Bio, INC., €15k.

Filing timeline

BuySale
Michael John Dawson

Insider track record

Disclosed buys
1
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-50.0%

Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.

Signal history

No signal scores available.

Michael John Dawson: trading record in brief

Only one filing by Michael John Dawson is known so far (31 March 2022): an open-market purchase, €15k, in Palisade Bio, Inc. That is too little to draw conclusions. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to Michael John Dawson

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations1 total
  • ▲
    Chief Medical OfficerExecutivesPalisade Bio, Inc.
    17,093 USD38SEC
    15,000 shares@ US$1.1395100.0% of flowCommon StockSEC:0001209191-22-021681:0
    Canonical exit: 27 Jun 2022 (T+90)

1 of 1 declaration